Australia markets close in 5 hours 45 minutes

Acumen Pharmaceuticals, Inc. (ABOS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
3.7300-0.0700 (-1.84%)
At close: 04:00PM EDT
3.8000 +0.07 (+1.88%)
After hours: 04:58PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
42,318
42,318
32,361
12,305
7,997
Selling general and administrative
18,820
18,820
12,876
7,279
1,351
Total operating expenses
61,138
61,138
45,237
19,584
7,912
Operating income or loss
-61,138
-61,138
-45,237
-19,584
-7,912
Interest expense
581
581
0
-
-
Total other income/expenses net
-1,443
-1,443
-11
-81,106
586
Income before tax
-52,371
-52,371
-42,856
-100,606
-7,325
Income from continuing operations
-52,371
-52,371
-42,856
-100,606
-7,325
Net income
-52,371
-52,371
-42,856
-100,606
-7,325
Net income available to common shareholders
-52,371
-52,371
-42,856
-100,606
-7,325
Basic EPS
-1.11
-
-1.06
-5.02
-0.26
Diluted EPS
-1.11
-
-1.06
-5.02
-0.26
Basic average shares
44,340
-
40,602
20,058
28,652
Diluted average shares
44,340
-
40,602
20,058
28,652